Search

Your search keyword '"Peters Oliver"' showing total 1,404 results

Search Constraints

Start Over You searched for: Author "Peters Oliver" Remove constraint Author: "Peters Oliver" Language english Remove constraint Language: english
1,404 results on '"Peters Oliver"'

Search Results

1. Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia

2. GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)

3. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

4. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

5. The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis

7. Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

8. Fronto-striatal alterations correlate with apathy severity in behavioral variant frontotemporal dementia

9. The comorbidity and co-medication profile of patients with progressive supranuclear palsy

13. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease

14. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

15. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study

16. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

17. Exploring the ATN classification system using brain morphology

18. Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2

19. Fornix fractional anisotropy mediates the association between Mediterranean diet adherence and memory four years later in older adults without dementia

20. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

21. Linking early-life bilingualism and cognitive advantage in older adulthood

22. Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's disease

23. Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network

24. New insights into the genetic etiology of Alzheimer’s disease and related dementias

25. Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease.

26. Plasma amyloid beta X‐42/X‐40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease.

27. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

29. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

30. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.

31. Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age—Results from the Multicentre Observational DELCODE Study.

32. Short communication: Lifetime musical activity and resting-state functional connectivity in cognitive networks.

33. The Cerebrospinal Fluid Free-Glycans Hex 1 and HexNAc 1 Hex 1 Neu5Ac 1 as Potential Biomarkers of Alzheimer's Disease.

34. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

35. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

37. Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment

38. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

39. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies

40. Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.

42. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

45. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume

46. Computer-assisted prediction of clinical progression in the earliest stages of AD

49. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

50. Cognitive behavioural therapy for the treatment of late life depression: study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate)

Catalog

Books, media, physical & digital resources